STAA Stock Analysis: Buy, Sell, or Hold?

STAA - Staar Surgical Co

OPHTHALMIC GOODS
$18.70
0.36 (1.96%) ▲
5d: -1.42%
30d: -1.84%
90d: -20.02%
BUY
HIGH Confidence
Analysis Updated: Mar 31, 2026 12:00 AM ET
Earnings: May 06, 2026
Smart Money Accumulation

STAA is down 8.1% this week, but smart money is accumulating calls. Top strike: $20 2026-04-17 with 119 OI. Call ratio: 98% View Scanner →

Strength: 8.9/10

Get Alerted When STAA Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: STAA trading at deep discount. Market pricing in -23.2% annual earnings decline, creating value opportunity for patient investors.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$40.02
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$24.85
24.7% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: STAA is currently trading at $18.70, which is considered fair relative to its 30-day fair value range of $17.76 to $19.35. From a valuation perspective, the stock is trading at a discount (Forward PE: 22.8) compared to its historical average (50.2). Remarkably, the market is currently pricing in an annual earnings decline of 23.2% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, STAA is in a strong downtrend. Immediate support is located at $16.83, while resistance sits at $19.34.

Market Sentiment: STAA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Fair Price Range $17.76 - $19.35
Company Quality Score 57/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 78.6%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($19.72)

Fair Price Analysis

30-Day Fair Range $17.76 - $19.35
Current vs Fair Value FAIR

Support & Resistance Levels

Support Level $16.83
Resistance Level $19.34
Current Trend Strong Downtrend
Technical data as of Mar 31, 2026

Fundamental Context

Forward P/E (Next Year Est.) 22.75
Wall Street Target $19.72 (+5.5%)
Revenue Growth (YoY) 18.1%
Earnings Growth (YoY) -10.5%
Profit Margin -33.6%
Valuation Discount vs History -23.2% cheaper
PE vs Historical 22.8 vs 50.2 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -23.2% (market-implied from PE analysis)
1-Year Target $16.83 (-10%)
2-Year Target $15.15 (-19%)
3-Year Target $13.63 (-27%)
3-Yr Target (if PE normalizes) (PE: 23→50) $30.08 (+61%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.7, Growth: 38.9%) $50.06 (+168%)
Base: (SPY PE: 22.4, Growth: 38.9%) $49.18 (+163%)
Bear: (PE: 19.0, Growth: 38.9%) $41.80 (+124%)
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 22.7 to 50.2
Stabilization Target: $41.26 (+120.7%)
PE Expansion Potential: +120.7%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: March 31, 2026 11:30 PM ET
Data refreshes hourly during market hours. Next update: 12:30 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
10
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Broadwood Partners, L.P. BUY 316017 shares 2026-03-13
Broadwood Partners, L.P. BUY 299432 shares 2026-03-12
Broadwood Partners, L.P. BUY 54764 shares 2026-03-11

Unlock Insider Activity

See real-time buying/selling by company executives for STAA.

Create Free Account

Already have an account? Log In

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALC
Alcon AG
STRONG BUY
27 analysts
$94 54 HOLD
ISRG
Intuitive Surgical Inc
BUY
33 analysts
$607 48 HOLD
RGEN
Repligen Corporation
STRONG BUY
19 analysts
$186 61 BUY
WST
West Pharmaceutical Serv…
STRONG BUY
13 analysts
$318 62 BUY
RMD
ResMed Inc
BUY
19 analysts
$297 59 HOLD

Advanced STAA Option Strategies

Professional options setups generated by AI based on today's STAA price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for STAA

STAA Technical Chart STAA Price Prediction STAA Earnings Date STAA Investment Advisor STAA Fair Price Analyzer STAA Options Advisor STAA Options Chain STAA Options Analysis STAA Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals